Ashish Kacholia's Portfolio Company's Azadirachtin-Based Product Secures Government Approval for Revolutionary Public Health (Mosquito Control) Application
The company has a market cap of Rs 3,000 crore with an ROE of 30 per cent and an ROCE of 39 per cent.
Fineotex Chemical Limited (FCL) has received government approval for its innovative mosquito control solution, AquaStrike Premium. Developed by its subsidiary FSPL Private Limited, this Azadirachtin-based product has been approved by the Central Insecticide Board for import and formulation under the Insecticides Act, of 1968. This significant milestone highlights FCL's dedication to public health and environmental sustainability, offering a non-toxic, eco-friendly, and highly effective alternative to traditional mosquito control methods.
AquaStrike Premium, developed in Malaysia with European design engineering, is a unique, odourless, and invisible liquid solution that is simply sprinkled onto water surfaces to eradicate mosquito larvae. Unlike conventional insecticides, it eliminates the need for spraying and preserves water quality. Having undergone rigorous testing in WHO-approved laboratories and holding multiple international certifications, including approvals from the Malaysian Ministry of Health and Singapore's Public Utility Board, AquaStrike Premium is poised to revolutionize mosquito control strategies in India. FCL plans to collaborate with government agencies, NGOs, and healthcare organizations to implement large-scale programs, contributing to a healthier future.
Additionally, FCL's expansion into oil & gas and water treatment is showing promising results, with a robust order pipeline across diverse regions. The company's new plant, scheduled to begin operations in Q2 FY26, will significantly enhance its production capacity. FCL continues to prioritize innovation, developing 15 new products this quarter, including sustainable options like AquaStrike Premium, supporting both market growth and sustainability objectives. With over Rs 300 crore allocated for inorganic growth, FCL is poised to pursue strategic acquisitions. Reflecting its strong financial health, the Board has declared an interim dividend of Rs 0.40 per share, totalling Rs 4.58 crore. Further reinforcing this financial strength, ICRA recently upgraded FCL's credit ratings to A+ (Positive) for both long-term and short-term instruments. The company is confident in its future, driven by the growth of its new segments and the upcoming plant expansion.
DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.
About the Company
Fineotex Chemical Limited, a leading Indian multinational specialty performance chemical producer, offers sustainable, technology-driven solutions to diverse industries, notably textile & garment processing, clean and homecare, water treatment, and oil & gas. Operating state-of-the-art manufacturing facilities in Ambernath, Navi Mumbai (India) and Selangor (Malaysia), with an additional plant under construction in Ambernath, Fineotex prioritizes innovation and sustainability. Serving clients in 69 countries through a robust network of 102 distributors in India, and supported by a NABL-accredited R&D laboratory, Fineotex is dedicated to delivering innovative, reliable, and eco-friendly solutions tailored to the evolving needs of the global market.
According to Quarterly Results, the net sales decreased by 9 per cent to Rs 125.92 crore and net profit decreased by 15 per cent to Rs 27.63 crore in Q3FY25 compared to Q3FY24. In its nine-month results, the net sales decreased by 1 per cent to Rs 413.55 crore and net profit decreased by 2 per cent to Rs 89.08 crore in 9MFY25 compared to 9MFY24
An ace investor, Ashish Kacholia holds 31,35,568 shares or 2.74 per cent stake in the company as of December 2024. The company has a market cap of Rs 3,000 crore with an ROE of 30 per cent and an ROCE of 39 per cent. The stock gave multibagger returns of over 880 per cent returns in 5 years.
Disclaimer: The article is for informational purposes only and not investment advice.